×
App Icon
The Standard e-Paper
Fearless, Trusted News
★★★★ - on Play Store
Download App

Guarding the gains: Africa moves to tackle rising HIV drug resistance

For more than a decade, antiretroviral therapy has transformed HIV from a fatal infection into a manageable chronic condition. [Courtesy]

A major African-led research initiative is reshaping how the world detects and manages HIV treatment failure, as scientists warn that poor adherence and emerging drug resistance are quietly undermining progress in the global response. The multi-country Ndovu Study is generating critical real-world evidence expected to influence treatment guidelines across Africa and beyond, at a time when millions rely on modern antiretroviral therapy (ART) to survive and remain healthy.

Researchers in Kenya, Tanzania, Lesotho and Mozambique are collaborating on a landmark study to answer one of the most pressing clinical questions facing HIV programmes: what should be done when first-line therapy stops working, particularly when resistance develops to dolutegravir, the backbone of current treatment worldwide.

Premium Article

Get Full Access for Ksh299/Week.

Uncover the stories others won't tell. Subscribe now for exclusive access.
Continue Reading  →
What you get
  • Unlimited access to all premium content
  • Ad-free browsing experience
  • Mobile-optimised reading
  • Weekly newsletters & digests
Pay via
M - PESA
VISA
Airtel Money
Secure Payments Kenya's most trusted newsroom since 1902